Guest guest Posted July 25, 2011 Report Share Posted July 25, 2011 J & J Wins European Panel's Backing of Cancer, Hepatitis Drugs Bloomberg By Connolly and Nussbaum - Fri Jul 22 16:09:45 GMT 2011 & (JNJ) won the backing of a European panel today for approval of its hepatitis C treatment Incivo and prostate-cancer drug Zytiga, each projected by analysts to top ... See all stories on this topic »Rapist infected woman with hepatitis C BBC News A sex attacker who infected a woman with hepatitis C when he broke into her south London home and raped her has been jailed indefinitely. The victim, aged in her 50s, was in bed when she awoke to find Lee Brophy, armed with a knife, standing over her. ... See all stories on this topic »Vertex, J & J Hepatitis Drug Moves Closer to EU Approval Minyanville.com Vertex Pharmaceuticals' (VRTX) and & 's (JNJ) hepatitis C drug moved a step closer to receiving European approval, setting up another battle with Merck (MRK). A panel of advisers to the European Medicines Agency says the drug should be ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 25, 2011 Report Share Posted July 25, 2011 J & J Wins European Panel's Backing of Cancer, Hepatitis Drugs Bloomberg By Connolly and Nussbaum - Fri Jul 22 16:09:45 GMT 2011 & (JNJ) won the backing of a European panel today for approval of its hepatitis C treatment Incivo and prostate-cancer drug Zytiga, each projected by analysts to top ... See all stories on this topic »Rapist infected woman with hepatitis C BBC News A sex attacker who infected a woman with hepatitis C when he broke into her south London home and raped her has been jailed indefinitely. The victim, aged in her 50s, was in bed when she awoke to find Lee Brophy, armed with a knife, standing over her. ... See all stories on this topic »Vertex, J & J Hepatitis Drug Moves Closer to EU Approval Minyanville.com Vertex Pharmaceuticals' (VRTX) and & 's (JNJ) hepatitis C drug moved a step closer to receiving European approval, setting up another battle with Merck (MRK). A panel of advisers to the European Medicines Agency says the drug should be ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.